Characterizing executive functioning in older special populations: From cognitively elite to cognitively impaired.

The authors examined the structure and invariance of executive functions (EF) across (a) a continuum of cognitive status in 3 groups of older adults (cognitively elite [CE], cognitively normal [CN], and cognitively impaired [CI]) and (b) a 3-year longitudinal interval. Using latent variable analyses (LISREL 8.80), the authors tested 3-factor models (“Inhibition”: Hayling [Burgess & Shallice, 1997], Stroop [Regard, 1981]; “Shifting”: Brixton [Burgess & Shallice, 1997], Color Trails [D’Elia et al., 1996]; and “Updating”: Reading and Computational Span [Salthouse & Babcock, 1991]) and 1-factor models within each group. Participants (initial N = 570; 53–90 years) were from the Victoria Longitudinal Study (Sample 3, Waves 1 and 2). Cross-sectionally, the authors observed a 3-factor EF structure especially for the CE group and 1-factor solutions for all 3 groups. Longitudinally, temporal invariance was supported for the 3-factor model (CE and CN groups) and the 1-factor model (CI and CN groups). Subgroups with higher cognitive status and greater 3-year stability performed better on EF factors than corresponding groups with lower cognitive status and less stability. Studies of EF structure, performance, dedifferentiation, and dysfunction will benefit from considering initial cognitive status and longitudinal stability. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Probabilistic performance prediction model for Austrian torrent control infrastructure

Due to the growing stock of torrent control structures and decreasing investments, the protection level can be reduced in the long term. Therefore, the focus of the future investments has been shifted on efficiency improvement and maintenance of existing structures. The maintenance of the existing structures is necessary to ensure safety from natural hazards, which are increasing as a consequence of the climate change. Due to the increasing number of structures, there is a strong need to develop a good maintenance management for these infrastructure works. This study is based on data from the condition rating programme of the Austrian Service for Torrent and Avalanche Control. For the structures relevant in this work, 75,343 records were available. The data were examined for different construction type and construction materials. The reliability of the structures was determined by means of the Markov chain. The study describes a homogeneous Markov chain model formed by the data of the condition rating. The result of this study is a proposal for a time to failure (TTF) and a time to repair (TTR) for several construction types with different construction materials as well as the time-dependent use of construction materials in the sector of the Austrian torrent control infrastructure.     

The relation between induced abortion and ectopic pregnancy

The present study was conducted to elucidate the effects of tirilazad mesylate (U-74006F), a potent inhibitor of lipid peroxidation, on vessel diameter, capillary perfusion, and contractile function of rat cremaster muscle during a 90-minute reperfusion period that followed 4 hours of warm ischemia. Two groups of 32 animals were treated with either 3 mg/kg U-74006F or the vehicle (citrate buffer) alone 30 minutes before ischemia, 90 minutes after ischemia, and immediately before reperfusion. With use of intravital videomicroscopy, the internal luminal diameters of preselected vessels were measured prior to ischemia and during reperfusion. The area that filled with fluorescein was determined at 15-minute intervals for as long as 90 minutes of reperfusion, and contractile function was examined in vitro in an organ bath at that point. In the U-74006F group, after 90 minutes of reperfusion the vessel diameters returned completely to baseline and the diameters of all three categories of vessels at every time point from 10 to 90 minutes of reperfusion had significantly more rapid recovery than the controls. Although some evidence of more rapid fluorescence was noted in the U-74006F group, the two groups did not differ significantly at any time period of reperfusion. In response to tetanic stimulation, the muscles treated with U-74006F had a significantly greater contractile force at all stimulation frequencies than the control muscles. Our findings indicate that pretreatment with U-74006F can effectively decrease the rise of vascular resistance and preserve the contractile function of skeletal muscle during early reperfusion, thereby attenuating ischemia-reperfusion injury.     

Risk factors for cognitive impairment in epilepsy.

The literature suggests that seizure disorders are associated with an increased likelihood of intellectual problems, prompting researchers to investigate risk factors of cognitive impairment in epileptic patients. This study examined the contribution of certain variables (age of seizure onset, duration, etiology, seizure location and laterality, sex, handedness, and cerebral speech pattern) to cognitive outcome in patients with medically refractory seizures. Seizure location (temporal or extratemporal), age of onset of seizures, and handedness proved to be the best indicators of general intellectual ability. There was a relatively diverse pattern of relationships when neuropsychological tests of language, visuospatial ability, and memory were considered individually. However, a factor analytic approach revealed a simpler pattern in which location of dysfunction, age at seizure onset, hand preference, cerebral speech dominance, and gender were relevant and independent indicators of verbal and nonverbal ability. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Strategies of therapeutic intervention—classification by restraining and driving forces.

Presents the conceptual framework for a new method of classification of strategies of therapeutic intervention. The classification is based on the terms driving force and restraining force, where a driving force operates in the direction of achieving the therapeutic aim and a restraining force operates against this direction. Seven strategies are identified, and each is illustrated by an example from the literature. The seven strategies are (a) enhancing the driving forces, (b) reducing the restraining forces, (c) preventing the driving forces from reducing each other's effects, (d) preventing the restraining forces from enhancing each other's effects, (e) causing the driving forces to enhance each other's effects, (f) causing the restraining forces to reduce each other's effects, and (g) transforming the restraining forces into driving forces. The theoretical and practical value of the classification is discussed. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options

The cytokine interleukin-6 is consistently detected in the brains of Alzheimer's disease patients but not in the brains of nondemented elderly persons. Until recently it was unclear whether an interleukin-6-associated inflammatory mechanism is an early or late event in the pathological cascade of Alzheimer's disease. We investigated whether interleukin-6 could be detected in plaques of Alzheimer's disease patients prior to the onset of neuritic degeneration. We found interleukin-6 mostly in plaques where neuritic pathology has not yet developed. This indicates that the appearance of interleukin-6 may precede neuritic changes and is not just a consequence of neuritic degeneration. Therefore, one may hypothesize that activation of inflammatory mechanisms may cause neuritic degeneration in plaques. A suppression of interleukin-6 synthesis could, therefore, be of therapeutic value. Upon screening a number of substances, we found that a small number of nonsteroidal antiinflammatory drugs, including tenidap, were able to inhibit interleukin-6 synthesis in cultured human astrocytoma cells. These substances may be therapeutically useful in Alzheimer's disease and should be evaluated in clinical studies.